Celgene MS Drug Wins In Trial; Will Safety Top Novartis, Biogen?
Celgene got good marks for a phase three trial for its MS drug. (Kris Tripplaar/Sipa USA/Newscom) ALLISON GATLIN 2/17/2017 Reprints ...
Celgene got good marks for a phase three trial for its MS drug. (Kris Tripplaar/Sipa USA/Newscom) ALLISON GATLIN 2/17/2017 Reprints ...
A pedestrian passes the sign outside the headquarters of Biogen Idec Inc. in Cambridge, Massachusetts June 18, 2008. (REUTERS/Brian Snyder) ...
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.